GREATER DELAWARE VALLEY SOCIETY OF TRANSPLANT SURGEONS (EIN 237388767) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1974

Legal Domicile

Principal Officer

RICHARD D HASZ

Phone

2155578090

Tax Period

2023-01-01 to 2023-12-31

GREATER DELAWARE VALLEY SOCIETY OF TRANSPLANT SURGEONS, founded in 1974, is a major nonprofit in the Medical Research sector that reported $134.5M in total revenue in fiscal year 2023. Expenses of $126.4M left a modest 6% surplus.

Mission

TO RECOVER AND ALLOCATE ORGANS AND TISSUES USED IN LIFE-SAVING AND LIFE-ENHANCING TRANSPLANTS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $132,691,255

Investment Income $1,808,909

Other Revenue $-45,063

TOTAL REVENUE $134,455,101

Expense Breakdown

Grants Paid $0

Salaries & Benefits $40,420,138

Fundraising Expenses $0

Program Expenses $117,785,539

Other Expenses $85,940,654

TOTAL EXPENSES $126,360,792

Year-over-Year Comparison

	2023	2022	Change
Revenue	$134,455,101	$125,543,961	+0.1%
Expenses	$126,360,792	$118,985,440	+0.1%
Net Income	$8,094,309	$6,558,521	+0.2%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✓ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

332

Volunteers

600

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✓ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$2,130,426

Total Directors

$946,726

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
RICHARD D HASZ	PRESIDENT AND CEO	51.00	Officer Director	$794,105	$152,621	$946,726
BARBARA WADSWORTH DNP RN	IMMEDIATE PAST CHAIR	0.70	Officer Director	$0	$0	$0
WARREN MALEY MD	CHAIR	0.85	Officer Director	$0	$0	$0
MARGARET BELFIELD	TREASURER & SECRETARY	0.50	Officer Director	$0	$0	$0
CLYDE F BARKER MD	HONORARY CHAIRMAN & CO-FOUNDER	0.70	Officer Director	$0	$0	$0
LINDA BARRASSE MD	VICE CHAIR	0.50	Officer Director	$0	$0	$0
TIMMY NELSON	DIRECTOR	0.40	Director	$0	$0	$0
LYNN FALLON	DIRECTOR	0.40	Director	$0	$0	$0
DAVID J REICH MD FACS	DIRECTOR	0.40	Director	$0	$0	$0
NIELS D MARTIN MD	DIRECTOR	0.40	Director	$0	$0	$0
DIANE WILSON	DIRECTOR	0.40	Director	$0	$0	$0
JAN L WEINSTOCK ESQ	CHIEF ADMIN. OFFICER & GEN.	47.00	Officer	$640,421	$71,156	$711,577
CHRISTINE RADOLOVIC	CHIEF CLINICAL OFFICER	45.00	Officer	$416,540	$55,583	$472,123
JOHN F RENZ	ORGAN RECOVERY SURGEON	45.00	Highest	$414,677	$54,106	$468,783
JOHN EDWARDS	CLINICAL OPERATIONS ADMINISTRATOR	45.00	Highest	$254,440	$48,735	$303,175
RICHARD J RYAN	VP OF ORGAN & TISSUE RECOVERY SER.	40.00	Highest	$238,821	$33,865	$272,686
ELIZABETH S BROWN	VP, TRANSPLANT COORDINATION	40.00	Highest	$237,736	$26,287	$264,023
GWENETH O'SHAUGHNESSY	VP, HOSPITAL SERVICES	40.00	Highest	$236,467	$50,888	$287,355
HOWARD NATHAN	FORMER OFFICER/FOUNDATION EX DIR	0.00		$0	$60,491	$387,665

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$134,455,101	$126,360,792	$140,087,921	$8,094,309
2022	$125,543,961	$118,985,440	$126,016,546	$6,558,521
2021	$115,440,008	$113,208,797	$121,450,335	$2,231,211
2020	$102,693,100	$92,648,126	$115,694,585	$10,044,974
2019	$101,919,082	$89,002,623	$102,561,119	$12,916,459
2018	$89,854,991	$79,841,051	$87,093,650	$10,013,940

GREATER DELAWARE VALLEY SOCIETY OF TRANSPLANT SURGEONS